Physician profile
James Petros
NPI 1194994996
$5,622.69
in general payments reported to CMS, 2019-2025
23 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,308 · 2020: $649 · 2021: $1,274 · 2022: $659 · 2023: $503 · 2024: $119 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,722.27 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Pacira Pharmaceuticals Incorporated | $738.00 | 2019 | |
| Allergan, INC. | $465.60 | 2019-2022 | |
| Stimwave Technologies Incorporated | $447.40 | 2019-2022 | |
| Painteq LLC | $178.82 | 2021 | |
| Spr Therapeutics, INC | $164.32 | 2019-2023 | Sprint Pns System |
| Vertiflex, INC. | $132.75 | 2019 | |
| Medtronic, INC. | $103.75 | 2022 | |
| Vertos Medical, INC. | $102.48 | 2020-2024 | Mild Device Kit |
| Abbvie INC. | $84.33 | 2021-2025 | |
| Electronic Waveform Lab, INC. | $81.67 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $71.85 | 2021 | |
| Mml US, INC. | $57.84 | 2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $46.22 | 2023 | Belbuca, Xtampza |
| Nalu Medical, INC. | $41.40 | 2022-2023 | Nalu Neurostimulation System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $38.56 | 2024 | Proclaim |
| Masimo Corporation | $27.14 | 2023 | Patient Safetynet System |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.32 | 2022 | |
| Stryker Corporation | $22.83 | 2019 | |
| Pfizer INC. | $21.41 | 2023 | |
| Relievant Medsystems, INC. | $17.84 | 2021 | |
| Indivior INC. | $16.79 | 2019 | |
| Si-Bone, INC. | $16.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Petros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.